Project Description
Betahistine
tablet 24 mg
international nonproprietary name
Betahistine
Ref
BM-0031
Pharmacotherapeutic group
Not established
Composition of the preparation
Not established
Pharmacological action
Not established
Indications
Not established
Special indication
Not established
Special warning
Not established
Dosage and method of administration
24 mg
Overdosage
Not established
Safety measures
Not established
Side effects
Not established
Contraindications
Not established
Interactions with other medicinal preparations
Not established
The form of release
tablet – amount in packaging : 30